President Donald Trump said Medicaid programs in 50 states will get "most favored nation" pricing, part of his administration ...

Ahead of the midterm elections, the president said that all states had opted in to an effort to align Medicaid’s prices for ...

This week, a Senate committee scheduled a hearing for President Trump’s nominee to lead FDA, new reporting sheds light on the ...

Today, President Donald J. Trump announced that all 50 States’ Medicaid programs will benefit from lower prescription drug prices under his agreements with pharmaceutical manufacturers to match the ...

For decades, Presidents have promised to cut prescription drug prices, but only President Donald J. Trump has delivered.

EMPAVELI significantly reduced proteinuria in adolescents with kidney diseases, following an FDA label expansion for this age group. Biogen has announced that adolescents treated with EMPAVELI® ...

EMPAVELI-treated adolescents achieved a 75% relative reduction in proteinuria within 6 months versus placebo ; EMPAVELI is the only approved treatment for adolescents with C3G and ...

Biogen published results from a prespecified adolescent subgroup analysis of the Phase 3 VALIANT study evaluating EMPAVELI (pegcetacoplan) in the Clinical Journal of the American Society of Nephrology ...

The Trump administration's efforts to lower drug prices included promised changes to Medicaid. But it's still unclear which ...

Remedi SeniorCare Holding Corporation (Remedi), headquartered in Towson, Maryland, has agreed to pay over $5.3 million to the United States to resolve allegations that it violated the False Claims Act ...

EMPAVELI-treated adolescents achieved a 75% relative reduction in proteinuria within 6 months versus placebo EMPAVELI is the only approved ...

Morgan Stanley 24th Annual Global Healthcare Conference September 16, 2026 11:30 AM EDTCompany ParticipantsKabir Nath - ...